Teleflex - TFX Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TFX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TFX, but not buy additional shares or sell existing shares.
View TFX analyst ratings or view top-rated stocks.

13 equities research analysts have issued 1-year target prices for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $400.00. On average, they predict the company's share price to reach $271.46 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.

Teleflex's stock was trading at $328.48 at the start of the year. Since then, TFX stock has decreased by 28.2% and is now trading at $235.97.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TFX earnings forecast.

Teleflex Incorporated (NYSE:TFX) released its earnings results on Thursday, October, 27th. The medical technology company reported $3.27 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.16. The medical technology company had revenue of $686.80 million for the quarter, compared to analysts' expectations of $691.52 million. Teleflex had a trailing twelve-month return on equity of 16.26% and a net margin of 14.76%. The firm's revenue for the quarter was down 1.9% on a year-over-year basis. During the same period last year, the firm posted $3.51 earnings per share.
Read the conference call transcript.

Teleflex declared a quarterly dividend on Thursday, October 27th. Investors of record on Tuesday, November 15th will be given a dividend of $0.34 per share on Thursday, December 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Monday, November 14th.
Read our dividend analysis for TFX.

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.58%. The dividend payout ratio is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 10.03% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

Teleflex updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided EPS guidance of $12.80-$13.20 for the period, compared to the consensus estimate of $13.10. The company issued revenue guidance of $2.79 billion-$2.82 billion, compared to the consensus revenue estimate of $2.81 billion.

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.38%), BlackRock Inc. (7.19%), State Street Corp (4.34%), Price T Rowe Associates Inc. MD (3.09%), Ceredex Value Advisors LLC (1.87%) and TD Asset Management Inc. (1.14%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TFX stock can currently be purchased for approximately $235.97.

Teleflex (NYSE:TFX) has a market capitalization of $11.07 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $8.72 on an earnings per share basis.

The company employs 14,000 workers across the globe.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.